What Has Been The Historical And Current Growth Of The Intracranial Hemorrhage Devices Market?
The intracranial hemorrhage devices market has seen considerable growth due to a variety of factors.
• The market for intracranial hemorrhage devices has seen robust growth over the past few years. The market size is projected to increase from $1.71 billion in 2024 to $1.80 billion in 2025, yielding a compound annual growth rate (CAGR) of 5.5%.
Factors such as a surge in hemorrhagic conditions, encouraging government initiatives, favorable healthcare policies, an increase in lifestyle diseases, and a higher number of neurological specialty clinics have contributed to the growth observed in the historic period.
What Are The Predictions for The Intracranial Hemorrhage Devices Market Size In The Coming Years?
The intracranial hemorrhage devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the intracranial hemorrhage devices market in the coming years. The market is projected to attain a value of $2.22 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.3%.
Factors propelling this growth over the forecast period include the escalating incidence of traumatic injuries, a concerted effort to decrease the duration of hospital stays, the swelling adoption of wearables for monitoring, a surge in the demand for custom-made medicine, and the increasing reliance on robotics. Key trends for the forecast period consist of the creation of portable appliances, improvements in imaging devices, enhancements in monitoring devices, the rise of 3D printing technology, and the application of machine learning in medical imaging.
What Are The Leading Drivers Of Growth In The Intracranial Hemorrhage Devices Market?
An increase in brain disorder instances is slated to boost the expansion of the intracranial hemorrhage devices market. Brain disorders include a plethora of conditions that interfere with the brain's architecture, functionality, or chemical composition, disrupting regular cerebral operations. The burgeoning cases of these disorders stem from a combination of factors including bettered diagnostic methods, aging populations, changes in lifestyle habits, amplified awareness, and an increase in stress levels. Devices for intracranial hemorrhage are implemented to effectively diagnose, track, and address brain disorders that entail bleeding. They accomplish this by identifying hemorrhages, managing pressure, and eliminating blood clots, thereby averting further potential brain damage. For example, as per the National Institutes of Health, a governmental agency based in the US, it was estimated that the number of new primary brain and other CNS tumors rose from 93,470 in 2022 to 94,390 in 2023 in the United States. Thus, the escalation in brain disorder instances is propelling the growth of the intracranial hemorrhage devices market.
What Are The Core Segments Of The Globa Intracranial Hemorrhage Devices Market?
The intracranial hemorrhage devices market covered in this report is segmented –
1) By Product Type: Diagnosis, Treatment
2) By Devices: Invasive, Non-Invasive
3) By End Users: Hospitals, Ambulatory Surgical Centres, Other End Users
Subsegments:
1) By Diagnosis: MRI (Magnetic Resonance Imaging) Devices, CT (Computed Tomography) Scanners, Ultrasound Devices, EEG (Electroencephalogram) Devices, Intracranial Pressure Monitors, Blood Gas Analyzers
2) By Treatment: Surgical Instruments (Craniotomy Instruments), Drainage Devices (Ventriculostomy Catheters), Embolization Devices, Hemostatic Agents, Coagulation Devices, Neurostimulation Devices
Pre-Book The Intracranial Hemorrhage Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Intracranial Hemorrhage Devices Market?
Major corporations in the intracranial hemorrhage devices market are prioritizing the development of ground-breaking products like advanced neuro access devices to improve the accuracy and productivity of diagnosing and treating neurological injuries. Advanced neuro access devices are specialized medical instruments and technologies explicitly built to provide accurate access to the brain or nervous system for diagnosis, surgery, or therapy. For example, Penumbra Inc., a US medical device company, announced in June 2024 the European introduction of its sophisticated neuro access devices, BMX81 and BMX96. These devices, formulated to manage ischemic and hemorrhagic strokes, feature innovative laser-cut stainless steel hypotube technology to enhance stability and trackability, and also enable larger inner diameters. The launch underscores Penumbra's dedication to improving stroke care in Europe.
Who Are the Key Players in the Intracranial Hemorrhage Devices Market?
Major companies operating in the intracranial hemorrhage devices market are include:
• Johnson & Johnson Services Inc.
• Medtronic Inc.
• Siemens Healthcare GmbH
• Stryker Corporation
• General Electric Company
• Terumo Corporation
• Canon Medical Systems Corporation
• Penumbra Inc.
• MicroPort Scientific Corporation
• Aidoc Medical Ltd.
• Viz.ai Inc.
• Phenox GmbH
• RAPID AI Inc.
• Acandis GmbH
• Kaneka Medix Corporation
• Hyperfine Inc.
• ClearMind Biomedical Inc.
• InfraScan Inc.
• Schindler Endoskopie Technologie GmbH
• Sense Neuro Diagnostics Inc.
• MaxQ AI Inc.
• Invamed Inc.
What are the Regional Insights into the Intracranial Hemorrhage Devices Market?
North America was the largest region in the intracranial hemorrhage devices market in 2024. The regions covered in the intracranial hemorrhage devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
